|
09 Sep 2025 |
LTIMindtree
|
Consensus Share Price Target
|
5185.50 |
5380.35 |
- |
3.76 |
hold
|
|
|
|
|
28 Apr 2023
|
LTIMindtree
|
Sharekhan
|
5185.50
|
5100.00
|
4419.45
(17.33%)
|
Target met |
Buy
|
|
|
|
|
28 Apr 2023
|
LTIMindtree
|
ICICI Securities Limited
|
5185.50
|
5637.00
|
4320.15
(20.03%)
|
Target met |
Buy
|
|
|
LTIMindtree (LTIM) has reported Q4FY23 revenue at US$1057.5mn, +0.7% QoQ in CC terms and +1% QoQ in US$ (in line with our estimate and lower than consensus estimate of 2.8% QoQ US$). Revenue growth was led by BFSI (2.6% QoQ US$), retail, CPG, travel (2.4% QoQ US$) and manufacturing (1% QoQ US$), while HiTech declined 1.5% QoQ US$ due to decision-making delays by clients in starting certain projects.
|
|
28 Apr 2023
|
LTIMindtree
|
ICICI Direct
|
5185.50
|
5320.00
|
4419.45
(17.33%)
|
Target met |
Buy
|
|
|
|
|
15 Mar 2023
|
LTIMindtree
|
Sharekhan
|
5185.50
|
5170.00
|
4553.05
(13.89%)
|
Target met |
Buy
|
|
|
|
|
15 Mar 2023
|
LTIMindtree
|
ICICI Securities Limited
|
5185.50
|
5651.00
|
4566.95
(13.54%)
|
Target met |
Buy
|
|
|
We attended LTIMindtree (LTIM) Investor Day 2023 (on Mar 14), wherein the management reiterated its aspiration to achieve US$1bn incremental revenue through cross-sell synergies over the next 2-4 years and reach 19-20% EBIT margins by FY27 i.e. improvement of ~200bps on pro-forma margins of the combined entity as on FY22.
|
|
15 Mar 2023
|
LTIMindtree
|
ICICI Direct
|
5185.50
|
5320.00
|
4592.30
(12.92%)
|
Target met |
Buy
|
|
|
|
|
15 Mar 2023
|
LTIMindtree
|
IDBI Capital
|
5185.50
|
5000.00
|
4592.30
(12.92%)
|
Target met |
Hold
|
|
|
|
|
14 Mar 2023
|
LTIMindtree
|
Motilal Oswal
|
5185.50
|
4590.00
|
4566.95
(13.54%)
|
Target met |
Neutral
|
|
|
|
|
25 Feb 2023
|
LTIMindtree
|
Axis Direct
|
5185.50
|
5340.00
|
4853.55
(6.84%)
|
Target met |
Buy
|
|
|
Recommendation: We recommend a BUY rating on the stock with a near term TP of Rs 5340, implying an upside of 10% from CMP.
|
|
23 Jan 2023
|
LTIMindtree
|
Axis Direct
|
5185.50
|
4950.00
|
4368.85
(18.69%)
|
Target met |
Buy
|
|
|
Given the company's strong growth potential backed by robust deal wins and superior execution capabilities, we maintain our BUY recommendation on the stock
|